Efrat Kochba

Ness Ziona, M, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity.

Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity.

Journal: bioRxiv : the preprint server for biology

Published: October 20, 2022

Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity.

Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity.

Journal: iScience

Published: September 23, 2022

Robust humoral immune response against rabies virus in rabbits and guinea pigs immunized with plasmid DNA vectors encoding rabies virus glycoproteins - An approach to the production of polyclonal antibody reagents.

Robust humoral immune response against rabies virus in rabbits and guinea pigs immunized with plasmid DNA vectors encoding rabies virus glycoproteins - An approach to the production of polyclonal antibody reagents.

Journal: Molecular and cellular probes

Published: April 29, 2022

Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.

Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.

Journal: Immunotherapy advances

Published: September 13, 2021

Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptides.

Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptides.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: March 30, 2020

A Double-blind, Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod, in Patients on Dialysis.

A Double-blind, Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod, in Patients on Dialysis.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: January 06, 2020

Intradermal injection of lidocaine with a microneedle device to provide rapid local anaesthesia for peripheral intravenous cannulation: A randomised open-label placebo-controlled clinical trial.

Intradermal injection of lidocaine with a microneedle device to provide rapid local anaesthesia for peripheral intravenous cannulation: A randomised open-label placebo-controlled clinical trial.

Journal: PloS one

Published: September 25, 2019

Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy.

Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy.

Journal: International journal of pharmaceutics

Published: December 05, 2018

The adjuvant GLA-AF enhances human intradermal vaccine responses.

The adjuvant GLA-AF enhances human intradermal vaccine responses.

Journal: Science advances

Published: January 12, 2018

De Novo Synthesis of Elastin by Exogenous Delivery of Synthetic Modified mRNA into Skin and Elastin-Deficient Cells.

De Novo Synthesis of Elastin by Exogenous Delivery of Synthetic Modified mRNA into Skin and Elastin-Deficient Cells.

Journal: Molecular therapy. Nucleic acids

Published: November 23, 2017

Intradermal Delivery of Synthetic mRNA Using Hollow Microneedles for Efficient and Rapid Production of Exogenous Proteins in Skin.

Intradermal Delivery of Synthetic mRNA Using Hollow Microneedles for Efficient and Rapid Production of Exogenous Proteins in Skin.

Journal: Molecular therapy. Nucleic acids

Published: November 05, 2017

Cutaneous vaccination: Briefings of the third skin vaccination summit, September 2-4, 2015, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.

Cutaneous vaccination: Briefings of the third skin vaccination summit, September 2-4, 2015, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.

Journal: Vaccine

Published: March 13, 2017

Showing 1-12 of 22

Last Updated: 09/26/2026